Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Clinical trial NCT05366179 · RECRUITING
Trial details
- NCT number
- NCT05366179
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-02
- Primary completion
- 2030-05-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.